WHO-UMC IDMP Management and Publish API, published by Uppsala Monitoring Centre. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/Uppsala-Monitoring-Centre/WHO-UMC-IDMP-Service/ and changes regularly. See the Directory of published versions
Generated Narrative: MedicinalProductDefinition 1266520E021
version: 1; Last updated: 2024-02-18 00:52:26+0000;
Information Source: http://idmp.who-umc.org/fhir
identifier: http://who-umc.org/idmp/CodeSystem/product
/1266520E021
type: Medicinal Product
domain: Human use
status: Active
combinedPharmaceuticalDoseForm: TABLETS
Type | Contact |
Proposed Marketing Authorization Holder/Person | Sandoz |
code: WHODrug DrugCode 00113802085: 00113802085
name
productName: Methotrexaat sandoz
Usages
Country Jurisdiction Language Netherlands Netherlands Dutch
Generated Narrative: Organization #sandoz
name: Sandoz